Literature DB >> 6716957

Experimentally induced Tyzzer's disease in Mongolian gerbils (Meriones unguiculatus).

K S Waggie, J R Ganaway, J E Wagner, T H Spencer.   

Abstract

Tyzzer's disease was induced in outbred, 3- to 4-week-old female Mongolian gerbils (Meriones unguiculatus) by oral inoculation of either a yolk sac preparation containing spores or a suspension of infected mouse liver. Clinical signs and lesions were similar regardless of the inoculum. Nests of Bacillus piliformis were seen in follicle associated epithelium of ileal Peyer's patches by 24 hours post-inoculation. Disease severity peaked at the fifty through seventh days. Many animals died during this time, and they had lesions in the intestinal tract, liver, and myocardium. Lesions began to resolve in animals surviving past the seventh day of infection. Because of the unique susceptibility of gerbils to Bacillus piliformis infection, they may be useful as an aid to study the natural course of Tyzzer's disease and as sentinel animals. They also may serve as a valuable diagnostic tool as the recipient of suspect material.

Entities:  

Mesh:

Year:  1984        PMID: 6716957

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  3 in total

1.  Effects of neutrophil, natural killer cell, and macrophage depletion on murine Clostridium piliforme infection.

Authors:  R A Van Andel; R R Hook; C L Franklin; C L Besch-Williford; N van Rooijen; L K Riley
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 2.  Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.

Authors:  Timothy K Cooper; David K Meyerholz; Amanda P Beck; Martha A Delaney; Alessandra Piersigilli; Teresa L Southard; Cory F Brayton
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

3.  Interleukin-12 has a role in mediating resistance of murine strains to Tyzzer's disease.

Authors:  R A Van Andel; R R Hook; C L Franklin; C L Besch-Williford; L K Riley
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.